HLVX HilleVax Inc

About HLVX

HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.
50

Neutral Sentiment

How do you feel about HLVX?

Advertisement|Remove ads.